Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 135 results for "genentech rank"

Genentech Says Late-stage GALLIUM Study Meets Primary Endpoint...

Genentech, a member of the Roche Group (RHHBY.PK), announced positive results from the pivotal Phase III GALLIUM study in people with previously untreated follicular lymphoma, the most common type of indolent (slow-growing) non-Hodgkin's lymphoma or ... RTTNews.com, 1 day ago

2 images for "genentech rank"

BioSpace, 1 month ago
Yahoo! Singapore, 1 month ago
Zacks.com

Kite Pharma (KITE) Upgraded to Hold on Strong Fundamentals

On May 12, Zacks Investment Research upgraded Kite Pharma, Inc . KITE to a Zacks Rank #3 (Hold) from a Zacks Rank #4 (Sell) Why the Upgrade? Kite reported results for the first quarter 2016 on May 9. Kite's track record has been satisfactory so ...
 Yahoo! Finance UK and Ireland2 weeks ago
[x]  
Nasdaq

Kite Collaborates with Roche for Immunotherapy Cocktail

Kite Pharma, Inc . KITE announced that it has entered into a collaboration agreement with Roche Holding's RHHBY Genentech for its immunotherapy candidate, KTE-C19. Per the terms of the agreement, the companies will collaborate to evaluate the ...
 Yahoo! Singapore2 months ago
[x]  

Sporadic Steroids May Be as Effective as Daily Dose For Some Preschoolers With Wheezing

UCSF-Led Study Suggests Asthma Treatment Guidelines Due for Update Children aged 6 and under with intermittent wheezing triggered by colds may not need to take inhaled steroids on a daily basis to limit the flare-ups that can result in emergency ...
 Health Canal1 day ago
TMC Net

Entelo Raises $12 Million in Series B Funding to Bring Data-Driven Recruiting to the Enterprise

/PRNewswire/ -- Entelo, the leading provider of enterprise software for data-driven recruiting, today announced that it has closed a $12 million Series B financing round led by venture capital firm Shasta Ventures. Existing investor Battery Ventures ...
 TickerTech.com3 days ago ntelo Raises $12 Million in Series B Funding to Bring Data-Driven Recruiting to the Enterprise  HRO Today2 days ago
[x]  

Exelixis' Cabozantinib Met Primary Endpoint in Phase II Renal Cell Carcinoma Study

Exelixis Announces Results from Randomized Phase 2 Trial CABOSUN Demonstrate Cabozantinib Significantly Improved Progression-Free Survival versus Sunitinib in Previously Untreated Advanced Renal Cell Carcinoma Exelixis to consult with regulatory ...
 BioSpace4 days ago Exelixis Announces Results from Randomized Phase 2 Trial CABOSUN Demonstrate Cabozantinib Significantly Improved Progression-Free Survival versus Sunitinib in Previously Untreated Advanced Renal Cell Carcinoma  Benzinga.com4 days ago EXELIXIS : Announces Results from Randomized Phase 2 Trial CABOSUN Demonstrate Cabozantinib Significantly Improved Progression-Free Survival versus Sunitinib in Previously Untreated Advanced Renal Cell Carcinoma  4 Traders4 days ago
[x]  

CHUGAI PHARMACEUTICAL : Anti-Cancer Agent AvastinĀ®, Obtained Approval for Additional Indication of Advanced or Recurrent Cervical Cancer

-- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that it gained approval by the Japanese Ministry of Health, Labour and Welfare (MHLW) on May 23, 2016, for 'advanced or recurrent cervical cancer,' as new additional indication for the ...
 4 Traders5 days ago

FDA Okays New, Targeted Treatment For Bladder Cancer

The U.S. Food and Drug Administration said that it approved Tecentriq or atezolizumab to treat the most common type of bladder cancer, called urothelial carcinoma. This is the first product in its class (PD-1/PD-L1 inhibitors) approved to treat this ...
 RTTNews.com1 week ago

Nurix Announces New Appointments to Its Board of Directors

By a News Reporter-Staff News Editor at Biotech Week Nurix, Inc., a private drug discovery company, announced the appointments of David Lacey, M.D., and Perry Karsen to the company's board of directors. In addition, Tim Kutzkey, Ph.D., a partner at ...
 Pharmacy Choice1 week ago
[x]  

Intrexon's (XON) CEO Randal Kirk on Q1 2016 Results - Earnings Call Transcript

Intrexon Corp (NYSE: XON ) Q1 2016 Earnings Conference Call May 10, 2016, 05:30 PM ET Executives Christopher Basta - Vice President, Investor Relations Randal Kirk - Chairman and Chief Executive Officer Joel Liffmann - Senior Vice ...
 Seeking Alpha2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less